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LYMPHOID RESPONSE IN 9, 10-
DIMETHYL -1 -2 -BENZANTHRACENE
(DMBA) INDUCED MAMMARY
TUMOURS OF THE RAT. R. HEIMANN,
J. C. HEUSON, W. PIESSENS, N. LEGNOS and
G. GALLEZ (introduced by F. J. LEJEUNE).
Department of Pathology and Laboratory of
Clinical Investigation, Institut Jules-Bordet,
Brussels.
The lymphoid response has been quanti-
fied in mammary tumours induced by a single
gastric instillation of 20 mg of DMBA in
female Sprague-Dawley rats at age 50 days.
The tumours have been classified histo-
logically as poorly differentiated, atrophic
and secreting (Archer and Orlando, Cancer
Res., 1968, 28, 217).
The early appearing hyperplastic alveolar
nodules considered by some as preneoplastic
nodules showed no lymphoid response while
true tumours of the same size induced a
response. The response decreased markedly
between 6 and 8 months after DMBA
administration.
Continuously growing tumours and un-
differentiated tumours usually showed a
lymphoid response. Atrophic tumours
generally showed no response and secreting
tumours never showed any response.
When the tumour growth was stimulated
by insulin, the lymphoid response was
greater than in control tumours.
PROGESTINS AND MAMMARY
CANCER INDUCTION. E. COEZY and
G. RUDALI. Fondation Curie, Institut du
Radium, Paris.
It seems that in the past little research
has been devoted to the carcinogenic risk
produced by progestins. An intensive pro-
gramme has been developed in our laboratory
in recent years to investigate this problem.
It has been found that norethynodrel,
ethynodiol diacetate and chlormadinone
acetate do not accelerate or raise the fre-
quencies of mammary tumours in intact
C3H, RIII and (C3H x RIII)F1 females but
norethynodrel and ethynodiol diacetate in-
duce such tumours with a high frequency in
castrated (C3H x RIII)F1 males. The same
compounds have accelerated the appearance
of the tumours in castrated (C3H x RIII)F1
females. Chlormadinone acetate does not
produce tumours in castrated males and does
not accelerate carcinogenesis in the spayed
females.
MAMMARY TUMOUR AND HEPA-
TOMA SUPPRESSION BY DIETARY
RESTRICTION IN C3H AVY MICE. C.
ROWLATT, L. M. FRANKS and M. U. SHERIFF.
Imperial Cancer Research Fund, London.
Dietary restriction has been shown to
reduce the incidence of some tumours in mice
(Tannenbaum and Silverstone, Cancer, N. Y.,
1957, 1, 306).
C3H Avy mice have the highest female
mammary tumour incidence of any inbred
mouse strain (Heston and Vlahakis, J. natn.
Cancer Inst., 1968, 40, 1161) Hepatomata
are common in the male. The strain carries
the mammary tumour virus. In spite ofthis,
in our experiments the incidence of these
tumours in males and females was abolished
completely and the lifespan extended by
simple dietary restriction. In the female
mammary gland development was inhibited.
The lack of a target tissue could explain the
absence of mammary tumours in the female
but does not explain the reduction of liver
tumours in either sex.
These results will be presented as an
example of environmental factors influencing
the development of tumours even in strongly
susceptible hosts.
THE DOSE RESPONSE FOR THE
INDUCTION OF KIDNEY TUMOURS
IN THE RAT BY A SINGLE DOSE
OF DIMETHYLNITROSAMINE. P. F.
SWANN. Courtauld Institute of Bio-
chemistry, Middlesex Hospital Medical
School, London, and D. G. KAUFMAN.
National Cancer Institute, Bethesda, Mary~
land, U.S.A.
Seven days on a protein deficient diet
protects the rat against the lethal effect of a
dose of dimethylnitrosamine so that a single
dose can be given sufficient to induce kidney
tumours in every animal (Swann and McLean,
Biochem. J., 1971, 124, 283). Using this
technique the dose response for the induction
of kidney tumours is now being determined.
This paper reports results obtained up to
80 weeks after injection of carcinogen.
Different doses have produced between 10%
and 97% incidence of tumours. Two types
of tumours have been found. The predomi-
nant tumour is a renal mesenchymal tumour